To correlate the EML4-ALK fusion gene with the NSCLC profile (including smoking status, gender, tumor types, stage and ethnic characteristics) and ascertain the relationship of EML4-ALK with EGFR and KRAS mutations, we performed the present meta-analysis of 6950 patients from 27 studies. Here, ALK is linked to non-small cell lung carcinoma.